Avacta Group plc (“Avacta” or the “Company”), which provides innovative, high value proprietary technologies and services to the pharmaceutical and diagnostics markets, announces that it has signed a commercial agreement with Pall Corporation (NYSE:PLL)(“Pall”). As part of the agreement, Avacta and Pall will collaborate to develop and market products and advanced analytical services for the […]
SOUTH SAN FRANCISCO, Calif., & AIRPORT CITY, Israel – Fluidigm Corporation, the inventor of integrated fluidic circuits (IFCs), has appointed Eisenberg Brothers Ltd. as its distributor in Israel. Eisenberg Brothers will offer Fluidigm’s complete portfolio of BioMark™, EP1™, and Access Array™ Systems and the complete line up of Dynamic Array™, Digital Array™ and Access Array […]
HOPKINTON, Mass. – Caliper Life Sciences, Inc. (NASDAQ: CALP) and Covaris Inc., Woburn, Mass., today announced a co-marketing agreement which will leverage Covaris’ acoustic DNA shearing platforms and Caliper’s automation and microfluidics technologies to develop automated workflows for next generation sequencing experiments. Caliper has developed a complete suite of solutions for library construction, sample analysis, […]
PLEASANTON, Calif. and STATE COLLEGE, Pa. – IntegenX Inc. and SoftGenetics LLC today announced that their GeneMarker HID forensics software will power the data analysis feature of IntegenX’s Apollo 200 RapidHIT DNA Profiling system for human identification. The incorporated software will enable the integrated system to produce unique human DNA profiles in standardized formats compatible […]
Chalfont St.Giles – GE Healthcare, a unit of General Electric Company (NYSE:GE) announced today that on 1 April 2011, Kieran Murphy will be promoted to succeed current Life Sciences President and CEO Peter Ehrenheim who will retire from GE after a transition period on July 31 2011. Kieran is currently GE Healthcare’s Head of Global […]
Precision System Science, Co., Ltd (PSS) announced today that PSS and Nordiag ASA (Oslo, Norway) have entered into basic development agreement of reagents for next generation sequencer, development of such reagents protocols for SX-8G Compact and the distribution of the reagents by both companies. The genetic analysis market, using next generation sequencer, is currently $1 […]
SOUTH SAN FRANCISCO, Calif. – Fluidigm Corporation (NASDAQ:FLDM) today announced that the underwriters of its initial public offering have exercised in full their over-allotment option to purchase an additional 833,750 shares of Fluidigm common stock at $13.50 per share, less underwriting discounts and commissions. Together with the shares sold pursuant to the over-allotment option, Fluidigm […]
IMGM Laboratories GMBH has purchased a Fluidigm Access Array™ System to use in its development and validation of targeted re-sequencing applications services. IMGM is the first Genomic Services Provider to offer the combination of the Fluidigm Access Array technology in conjunction with Roche’s 454 Next-Generation Sequencing Systems to its customers in Germany. The Fluidigm Access […]
FORT WORTH, Texas – The Center for Human Identification at the UNT Health Science Center recently received a three-year $3.5 million grant from Life Technologies Corporation (NASDAQ: LIFE), a leader in forensic DNA testing systems, to train researchers from around the world in forensic DNA analysis techniques. This first of its kind accelerated academic certification […]
MENLO PARK, Calif. – ForteBio®, Inc., a leading supplier of label-free technology that accelerates the development of biotherapeutic and pharmaceutical products, today announced the launch of its Octet RED96 System, as well as its new Dip and Read™ Protein L Biosensor for use on the company’s Octet platform. The product introductions further widen the scope […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
